172 related articles for article (PubMed ID: 37960979)
1. Latent transforming growth factor beta binding protein 4: A regulator of mitochondrial function in acute kidney injury.
Neikirk K; Ume AC; Prasad P; Marshall AG; Rockwood J; Wenegieme TY; McMichael KE; McReynolds MR; Williams CR; Hinton A
Aging Cell; 2023 Dec; 22(12):e14019. PubMed ID: 37960979
[TBL] [Abstract][Full Text] [Related]
2. LTBP4 Protects Against Renal Fibrosis via Mitochondrial and Vascular Impacts.
Su CT; See DHW; Huang YJ; Jao TM; Liu SY; Chou CY; Lai CF; Lin WC; Wang CY; Huang JW; Hung KY
Circ Res; 2023 Jun; 133(1):71-85. PubMed ID: 37232163
[TBL] [Abstract][Full Text] [Related]
3. Anti-latent TGFβ binding protein 4 antibody improves muscle function and reduces muscle fibrosis in muscular dystrophy.
Demonbreun AR; Fallon KS; Oosterbaan CC; Vaught LA; Reiser NL; Bogdanovic E; Velez MP; Salamone IM; Page PGT; Hadhazy M; Quattrocelli M; Barefield DY; Wood LD; Gonzalez JP; Morris C; McNally EM
Sci Transl Med; 2021 Sep; 13(610):eabf0376. PubMed ID: 34516828
[TBL] [Abstract][Full Text] [Related]
4. LTBP4 affects renal fibrosis by influencing angiogenesis and altering mitochondrial structure.
Su CT; Jao TM; Urban Z; Huang YJ; See DHW; Tsai YC; Lin WC; Huang JW
Cell Death Dis; 2021 Oct; 12(10):943. PubMed ID: 34645813
[TBL] [Abstract][Full Text] [Related]
5. Latent transforming growth factor binding protein 4 regulates transforming growth factor beta receptor stability.
Su CT; Huang JW; Chiang CK; Lawrence EC; Levine KL; Dabovic B; Jung C; Davis EC; Madan-Khetarpal S; Urban Z
Hum Mol Genet; 2015 Jul; 24(14):4024-36. PubMed ID: 25882708
[TBL] [Abstract][Full Text] [Related]
6. Role of LTBP4 in alveolarization, angiogenesis, and fibrosis in lungs.
Bultmann-Mellin I; Dinger K; Debuschewitz C; Loewe KMA; Melcher Y; Plum MTW; Appel S; Rappl G; Willenborg S; Schauss AC; Jüngst C; Krüger M; Dressler S; Nakamura T; Wempe F; Alejandre Alcázar MA; Sterner-Kock A
Am J Physiol Lung Cell Mol Physiol; 2017 Oct; 313(4):L687-L698. PubMed ID: 28684544
[TBL] [Abstract][Full Text] [Related]
7. Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice.
Heydemann A; Ceco E; Lim JE; Hadhazy M; Ryder P; Moran JL; Beier DR; Palmer AA; McNally EM
J Clin Invest; 2009 Dec; 119(12):3703-12. PubMed ID: 19884661
[TBL] [Abstract][Full Text] [Related]
8. LTBP4 in Health and Disease.
Su CT; Urban Z
Genes (Basel); 2021 May; 12(6):. PubMed ID: 34071145
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Latent TGFβ Binding Protein 4 in Muscle Ameliorates Muscular Dystrophy through Myostatin and TGFβ.
Lamar KM; Bogdanovich S; Gardner BB; Gao QQ; Miller T; Earley JU; Hadhazy M; Vo AH; Wren L; Molkentin JD; McNally EM
PLoS Genet; 2016 May; 12(5):e1006019. PubMed ID: 27148972
[TBL] [Abstract][Full Text] [Related]
10. Ltbp4 regulates Pdgfrβ expression via TGFβ-dependent modulation of Nrf2 transcription factor function.
Tomasovic A; Kurrle N; Wempe F; De-Zolt S; Scheibe S; Koli K; Serchinger M; Schnütgen F; Sürün D; Sterner-Kock A; Weissmann N; von Melchner H
Matrix Biol; 2017 May; 59():109-120. PubMed ID: 27645114
[TBL] [Abstract][Full Text] [Related]
11. Genotype-Specific Interaction of Latent TGFβ Binding Protein 4 with TGFβ.
Lamar KM; Miller T; Dellefave-Castillo L; McNally EM
PLoS One; 2016; 11(2):e0150358. PubMed ID: 26918958
[TBL] [Abstract][Full Text] [Related]
12. TGF-β promotes fibrosis after severe acute kidney injury by enhancing renal macrophage infiltration.
Chung S; Overstreet JM; Li Y; Wang Y; Niu A; Wang S; Fan X; Sasaki K; Jin GN; Khodo SN; Gewin L; Zhang MZ; Harris RC
JCI Insight; 2018 Nov; 3(21):. PubMed ID: 30385721
[TBL] [Abstract][Full Text] [Related]
13. Conditional knockout of TGF-βRII /Smad2 signals protects against acute renal injury by alleviating cell necroptosis, apoptosis and inflammation.
Yang Q; Ren GL; Wei B; Jin J; Huang XR; Shao W; Li J; Meng XM; Lan HY
Theranostics; 2019; 9(26):8277-8293. PubMed ID: 31754396
[No Abstract] [Full Text] [Related]
14. Latent transforming growth factor binding protein 4 (LTBP4) is downregulated in mouse and human DCIS and mammary carcinomas.
Kretschmer C; Conradi A; Kemmner W; Sterner-Kock A
Cell Oncol (Dordr); 2011 Oct; 34(5):419-34. PubMed ID: 21468687
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β, bioenergetics, and mitochondria in renal disease.
Casalena G; Daehn I; Bottinger E
Semin Nephrol; 2012 May; 32(3):295-303. PubMed ID: 22835461
[TBL] [Abstract][Full Text] [Related]
16. Latent transforming growth factor β-binding protein 4 is downregulated in esophageal cancer via promoter methylation.
Bultmann I; Conradi A; Kretschmer C; Sterner-Kock A
PLoS One; 2013; 8(5):e65614. PubMed ID: 23741501
[TBL] [Abstract][Full Text] [Related]
17. Genes involved in the transforming growth factor beta signalling pathway and the risk of intracranial aneurysms.
Ruigrok YM; Tan S; Medic J; Rinkel GJ; Wijmenga C
J Neurol Neurosurg Psychiatry; 2008 Jun; 79(6):722-4. PubMed ID: 18487557
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis-free secretome analysis of thoracic aortic aneurysm reinforces the central role of TGF-β cascade in patients with bicuspid aortic valve.
Rocchiccioli S; Cecchettini A; Panesi P; Farneti PA; Mariani M; Ucciferri N; Citti L; Andreassi MG; Foffa I
J Cardiol; 2017 Mar; 69(3):570-576. PubMed ID: 27298013
[TBL] [Abstract][Full Text] [Related]
19. Potential role for heparan sulfate proteoglycans in regulation of transforming growth factor-beta (TGF-beta) by modulating assembly of latent TGF-beta-binding protein-1.
Chen Q; Sivakumar P; Barley C; Peters DM; Gomes RR; Farach-Carson MC; Dallas SL
J Biol Chem; 2007 Sep; 282(36):26418-30. PubMed ID: 17580303
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction and the AKI-to-CKD transition.
Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
